The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Di(pyridin-2-yl)methylene)-N-(4-((dimethylamino)methyl)phenyl)hydrazine-1-carboxamide ID: ALA4527447
PubChem CID: 155545166
Max Phase: Preclinical
Molecular Formula: C21H22N6O
Molecular Weight: 374.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)Cc1ccc(NC(=O)NN=C(c2ccccn2)c2ccccn2)cc1
Standard InChI: InChI=1S/C21H22N6O/c1-27(2)15-16-9-11-17(12-10-16)24-21(28)26-25-20(18-7-3-5-13-22-18)19-8-4-6-14-23-19/h3-14H,15H2,1-2H3,(H2,24,26,28)
Standard InChI Key: OAFWNCIRIFOXAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
14.3985 -25.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3973 -25.8842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1054 -26.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8150 -25.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8122 -25.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1036 -24.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6907 -24.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9831 -25.0650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5234 -26.2912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2305 -25.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9388 -26.2889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2292 -25.0643 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6459 -25.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3542 -26.2867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0613 -25.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7668 -26.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4734 -25.8757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4725 -25.0576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7592 -24.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0556 -25.0617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2753 -24.6565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9833 -25.8822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3555 -27.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6471 -27.5126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6480 -28.3290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3569 -28.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0663 -28.3232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0619 -27.5082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
4 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
8 21 1 0
8 22 1 0
14 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.45Molecular Weight (Monoisotopic): 374.1855AlogP: 3.11#Rotatable Bonds: 6Polar Surface Area: 82.51Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.00CX Basic pKa: 8.71CX LogP: 3.04CX LogD: 1.71Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -1.51
References 1. Ma J, Ni X, Gao Y, Huang K, Liu J, Wang Y, Chen R, Wang C.. (2019) Identification and biological evaluation of novel benzothiazole derivatives bearing a pyridine-semicarbazone moiety as apoptosis inducers via activation of procaspase-3 to caspase-3., 10 (3): [PMID:31015910 ] [10.1039/C8MD00624E ]